Literature DB >> 31774918

Preclinical Model of Perianal Fistulizing Crohn's Disease.

Meredith Flacs1,2, Maxime Collard1,2, Sabrina Doblas3, Magaly Zappa3,4, Dominique Cazals-Hatem2,5, Léon Maggiori1,2, Yves Panis1,2, Xavier Treton2,6, Eric Ogier-Denis2.   

Abstract

BACKGROUND: Fistulizing anoperineal lesions (FAPLs) are common and severe complications of Crohn's disease (CD), exposing patients to the risk of anal sphincter alteration and permanent stoma. Due to the limited efficacy of current treatments, identifying new local therapies is mandatory. However, testing new treatments is currently limited because no relevant preclinical model of Crohn's-like FAPL is available. Thus, a reliable and reproducible experimental model of FAPLs is needed to assess new therapeutic strategies.
METHODS: Twenty-one rats received a rectal enema of 2,4,6-trinitrobenzensulfonic acid (TNBS) to induce proctitis. Seven days later, a transsphincteric fistula tract was created with a surgical thread, instilled with TNBS twice a week until its removal at day 7 (group 1), day 14 (group 2), or day 28 (group 3). In each rat, pelvic MRI was performed just before and 7 days after thread removal. Rats were sacrificed 7 days after thread removal for pathological assessment of the fistula tract.
RESULTS: The optimal preclinical model was obtained in group 3. In this group, 7 days after thread removal, all animals (9 of 9) had a persistent fistula tract visible on MRI with T2-hypersignal (normalized T2 signal intensity: 2.36 ± 0.39 arbitrary units [a.u.] [2.08-2.81]) and elevation of the apparent diffusion coefficient (1.33 ± 0.16 10-3 millimeter squared per seconds [1.18-1.49]). The pathological examination of the fistula tract revealed acute and chronic inflammation, granulations, fibrosis, epithelialization, and proctitis in the adjacent rectum.
CONCLUSIONS: This reproducible preclinical model could be used to assess the effectiveness of innovative treatments in perianal fistulizing CD.
© 2019 Crohn’s & Colitis Foundation. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Crohn’s disease; perianal fistula; preclinical model

Mesh:

Substances:

Year:  2020        PMID: 31774918     DOI: 10.1093/ibd/izz288

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  3 in total

1.  Establishing a rabbit model of perianal fistulizing Crohn's disease.

Authors:  Shuang-Shuang Lu; Wen-Jia Liu; Qiu-Ya Niu; Chun-Yan Huo; Yu-Qing Cheng; En-Jing Wang; Rong-Nan Li; Fang-Fang Feng; Yi-Ming Cheng; Rong Liu; Jin Huang
Journal:  World J Gastroenterol       Date:  2022-04-21       Impact factor: 5.374

2.  A Preclinical Validation of Iron Oxide Nanoparticles for Treatment of Perianal Fistulizing Crohn's Disease.

Authors:  Antoine Cazelles; Maxime K Collard; Yoann Lalatonne; Sabrina Doblas; Magaly Zappa; Camélia Labiad; Dominique Cazals-Hatem; Léon Maggiori; Xavier Treton; Yves Panis; Ulrich Jarry; Thomas Desvallées; Pierre-Antoine Eliat; Raphaël Pineau; Laurence Motte; Didier Letourneur; Teresa Simon-Yarza; Eric Ogier-Denis
Journal:  Int J Mol Sci       Date:  2022-07-28       Impact factor: 6.208

Review 3.  Evaluation of animal models of Crohn's disease with anal fistula (Review).

Authors:  Shuangshuang Lu; Keyuan Zhu; Yongxin Guo; Enjing Wang; Jin Huang
Journal:  Exp Ther Med       Date:  2021-07-08       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.